NASDAQ
Arbutus Biopharma Corp (ABUS) has a interest coverage ratio of -278.88x as of Wednesday, July 15, 2026. This represents a 41.04% decrease compared to its 12-month average of -197.72x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.